R42 Al & LONGEVITY FUND 3-1 LP
Raised
$4M
Investors
8
Min Invest
$500,000
AltStreet Analysis
·Generated from EDGAR primary sources
R42 AI & LONGEVITY FUND 3-1 LP is a Delaware limited partnership that has raised $3.6M from 8 investors under Rule 506(b) and Section 3(c)(1). This amended filing reports a $500K minimum investment and identifies RonJon Nag and Nhi Nguyen as executive officers, with Finally Fund Admin LLC serving as director. The fund operates in the longevity biotech sector.
This longevity biotech fund employs a 506(b) private placement exemption with a $500K minimum, positioning it at the high-net-worth tier typical of early-stage biotech pooled investment vehicles. The combination of Section 3(c)(1) and a relatively small initial close suggests a structure targeting fewer than 100 beneficial owners with a focus on specialized longevity science investments.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Finally Fund Admin LLC
Director · Austin, TX
Nhi Nguyen
Executive Officer · Austin, TX
RonJon Nag
Executive Officer · Palo Alto, CA
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
